The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Typically how long do these phase one trials last till completed & are they are on humans ? What is the timscale for the drug to be competed so that we get the $295 million?
Very exciting times to come!!
This will have a re-rate, starting at the late 30's or mid 40's and why not ? It has been held back by the uncertainty and now with that cloud gone and further advancements made on its projects, we should recover some of the losses of late....roll on some updates which may even drive the sp higher. Gla
And the payments are huge! Hope you get in
This C4XD is soon to get first trial in human milestone payment. This will re-rate quickly, my internet in spain not so good but hopefully i can get in on the open tommorow.
I see. Thanks.
companies often get a payment when a compound is first dosed in man.
Not sure what the terms are in this deal
I hope not. This is one share I'd like to get more of at a low price before it starts to realise its potential. And on a related note, would a company typically receive a significant milestone payment for the start of a Phase 1 trial?
Trial completion and success are obviously major achievements. But is the commencement seen as a major milestone?
Surely this has to bump up nicely Monday morning let’s see where this goes :)
And one would hope that the company’s portfolio of drug discoveries has progressed since the share price was at the 100p mark.
The payments alone are huge and this should rerate pretty soon
Notmyjob.
every small company posts that kind of mush it is just par for the course.
The key here is the big Indivior deal looks back on track as the company (INDV) has resolved there legal battle which looked like it might have sunk them 12 months ago.
Around the time of the deal the SP was well over 100p and now things have moved on as a compound is now in the clinic.
Even allowing for the dilution this should be getting back to around 80p not only for the potential milestone payments from this deal and other deals that should be close, but for potential as a takeover target.
Cheers HSD for taking the time to reply, I was starting to get the jist of things from reading different blogs.....all good and hopefully a re-rate on the cards. This share has been unloved for far too long.
Browsing the company’s website and you are met with:
“Creating the world’s most productive drug discovery engine.”
“Designing and creating best in class drug candidates.”
The share price may well get a boost next week, but if the company delivers on the above, who knows what the mcap will become.
Isthisawinner - C4X Discovery uses AI technology to discover and test drugs. Think of it as advanced computer simulation rather than lab work. At the moment, the only one they've discovered that has been made into a molecule that's due to enter Phase 1 trials is a drug they've licensed to Indivior that could earn C4XD up to $280m, subject to certain milestones being achieved. But Indivior have been dealing with a court case that could have put that project in jeopardy. So yesterday's news that that could have been put to rest is very positive news for both Indivior and C4XD.
Thank christ Invdv got settled, now let's see them drive forward and give us the next payment, can't be too far away now.. GLA
From article..
In May, the AIM-listed firm raised £1.6mln through an oversubscribed placing at 15p a throw to strengthen its balance sheet as its partnering and strategic collaborations progress and will boost working capital during the progression of its pipeline portfolio. C4X said the new funds should provide it with at least twelve months working capital.
In April C4X said its closely-watched NRF-2 activator programme for sickle cell disease and pulmonary arterial hypertension was down to a short-list of three molecules.
FTSE 250-listed drug group Indivior was preparing to take C4X’s treatment for opioid use disorder into the clinic as part of a deal worth US$294mln. Phase I and II studies will receive financial backing from the National Institutes of Health in the US.
Yep fully funded, last placing done just a couple of months ago in May....now fully derisked as INDV no longer at risk of going bust!
Yea. Little bit of news flowing over the weekend and should open above 20 Monday morning
Huge buy at the end
No placing needed as they have funds till Atleast next may. Things are looking good
https://www.proactiveinvestors.co.uk/companies/amp/news/219394/c4x-discovery-on-hunt-for-next-partnership-deal-219394.html
Sorry if bother you but whats the connection ?
Could be a nice end to the week
C4XD should benefit!
Seems very stagnant